Persistence of Phi6, a SARS-CoV-2 surrogate, in simulated indoor environments: Effects of humidity and material properties

Persistence of Phi6, a SARS-CoV-2 surrogate, in simulated indoor environments: Effects of humidity and material properties

Saved in:

Bibliographic Details
Main Authors:	Eloise Parry-Nweye, Zhenlei Liu, Yousr Dhaouadi, Xin Guo, Wenfeng Huang, Jianshun Zhang, Dacheng Ren
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703003/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments
by: Ajit Ahlawat, et al.
Published: (2020-07-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

Evaluation of a flow cytometry-based surrogate assay (FlowSA) for the detection of SARS-CoV-2 in clinical samples
by: Vinit Upasani, et al.
Published: (2025-02-01)

Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay
by: Danielle W. Ali, et al.
Published: (2024-12-01)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
by: Radi Taha Alsafi
Published: (2022-01-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient
by: Hanno Schmidt, et al.
Published: (2025-01-01)

Leveraging mobility data to analyze persistent SARS-CoV-2 mutations and inform targeted genomic surveillance
by: Riccardo Spott, et al.
Published: (2025-01-01)

Simulation of SARS-CoV-2 Aerosol Emissions in the Infected Population and Resulting Airborne Exposures in Different Indoor Scenarios
by: Michael Riediker, et al.
Published: (2020-10-01)

Disinfection of indoor air for the inactivation of SARS-CoV-2: a review of the effectiveness of UV-C technology and gaps in research
by: Elena Cristina Rada, et al.
Published: (2025-01-01)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
by: Cucunawangsih Cucunawangsih, et al.
Published: (2021-01-01)

Myocardial Damage in SARS-CoV-2 Infection
by: Elizabeth Sellén Sanchén, et al.
Published: (2020-11-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

Bat reservoirs related to SARS-CoV-2
by: Sebastian Iglesias
Published: (2020-09-01)

Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study)
by: Lotte Haverman, et al.
Published: (2022-07-01)

SARS-CoV-2 drug resistance and therapeutic approaches
by: Sania Batool, et al.
Published: (2025-01-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Ebola Virus and SARS-CoV-2: Similarities and Differences
by: Robert C. SIZEMORE, et al.
Published: (2020-07-01)

Gross Hematuria following SARS-CoV-2 Vaccination
by: Maryam Sattari, et al.
Published: (2023-01-01)

Human infection studies and the SARS-CoV-2 pandemic
by: Jörg Tremmel
Published: (2022-04-01)

Recent developments in the therapeutics of SARS-CoV-2 infection
by: Priyanka Nagu, et al.
Published: (2024-12-01)

Nonhuman primate antigenic cartography of SARS-CoV-2
by: Annika Rössler, et al.
Published: (2025-01-01)

Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection
by: Maria Alfreda Stincarelli, et al.
Published: (2025-01-01)

Adolescents with Persistent Symptoms Following Acute SARS-CoV-2 Infection (Long-COVID): Symptom Profile, Clustering and Follow-Up Symptom Evaluation
by: Marco Floridia, et al.
Published: (2024-12-01)

Respiratory Protective Equipment Reconsiderations in the Age of SARS-CoV-2
by: Wei-Ren Ke, et al.
Published: (2022-01-01)

Environmental biocontamination by SARS-CoV-2 Virus in the hospital setting
by: M Espejo Mambié, et al.
Published: (2025-01-01)

Reducing the Mobility of SARS-CoV-2 Variants to Safeguard Containments
by: Martin Hellwig, et al.
Published: (2021-08-01)

New Variant of SARS-CoV-2 Dynamics with Imperfect Vaccine
by: Taye Samuel Faniran, et al.
Published: (2022-01-01)

Cerebral Sinus Thrombosis Secondary to SARS-CoV-2 Infection
by: Mojtaba Khazaei, et al.
Published: (2021-01-01)

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines
by: Syed Mohammed Basheeruddin Asdaq, et al.
Published: (2022-01-01)

Clinicopathological Features of Cutaneous Findings of SARS-CoV-2 Infection
by: Bengu COBANOGLU, et al.
Published: (2022-09-01)

SARS-CoV-2 Infection in Cancer Patients: Essential Aspects
by: Juan Santiago Serna Trejos, et al.
Published: (2023-01-01)

Investigating SARS-CoV-2 Neutralising Antibody Response in Sheep
by: Milena Samojlović, et al.
Published: (2024-12-01)

Pathology of Red Blood Cells in Patients with SARS-CoV-2
by: Sona Hakobyan, et al.
Published: (2025-01-01)

Clozapine Serum Concentrations Are Disrupted by SARS-CoV-2 Vaccinations
by: Xenia A. K. Kersting, et al.
Published: (2023-01-01)

Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
by: Istvan Bartha, et al.
Published: (2024-11-01)

Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
by: Pablo N. Perez-Guzman, et al.
Published: (2023-07-01)

Assessing nanobody interaction with SARS-CoV-2 Nsp9.
by: Gennaro Esposito, et al.
Published: (2024-01-01)

Impact of SARS-CoV-2 on Ambient Air Particulate Matter in Tehran
by: Sasan Faridi, et al.
Published: (2024-12-01)

Stochastic Modelling of the Dynamics of the SARS-CoV-2 Epidemic: An Africa Perspective
by: Rasaki, Olawale Olanrewaju, et al.
Published: (2021)